CCL21 and systemic sclerosis: In the current ELISA2, serum levels of CCL21 were higher in SSc patients than healthy controls (0.50 ± 0.38ng/ml vs. 0.25 ± 0.12ng/ml, p<0.001) (Figure 4A, iii).